Clinical trials
Phase 1/2 COVID-19 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 12 |
| 2021 | 7 |
| 2022 | 5 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Unknown status | 11 |
| Terminated | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2 |
| Institute of Medical Biology, Chinese Academy of Medical Sciences | 2 |
| Sinovac Research and Development Co., Ltd. | 2 |
| Beijing 302 Hospital | 1 |
| CanSino Biologics Inc. | 1 |
| Children's Hospital of Fudan University | 1 |
| China National Biotec Group Company Limited | 1 |
| Chinese Academy of Sciences | 1 |
| Chongqing Public Health Medical Center | 1 |
| Guangzhou Institute of Respiratory Disease | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 27 |
| Acute Lung Injury | 1 |
| Critical Illness | 1 |
| Pneumonia | 1 |
| Pneumonia, Viral | 1 |
| Respiratory Distress Syndrome | 1 |
Trials
Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.